Literature DB >> 887530

A case of myasthenia gravis treated with steroids: some suggestions for the mechanisms underlying their effect.

P Dandona, E J Corkan, G E Sladen.   

Abstract

This report deals with a patient with long standing myasthenia gravis treated with a small dose of corticosteroids. The response to treatment was prompt and the post-therapeutic deterioration in function was minimal and cholinergic in nature. It is suggested that the dose of anticholinesterases be reduced concomitantly with the institution of steroid treatment.

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 887530      PMCID： PMC2496642          DOI： 10.1136/pgmj.53.620.321

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


  9 in total

1.  AN ELECTROPHYSIOLOGICAL INVESTIGATION OF NEUROMUSCULAR TRANSMISSION IN MYASTHENIA GRAVIS.

Authors:  D ELMQVIST; W W HOFMANN; J KUGELBERG; D M QUASTEL
Journal:  J Physiol       Date:  1964-11       Impact factor: 5.182

2.  The acetylcholine sensitivity of frog muscle fibres after complete or partial devervation.

Authors:  R MILEDI
Journal:  J Physiol       Date:  1960-04       Impact factor: 5.182

3.  Benefit from adrenocorticotrophin in myasthenia gravis.

Authors:  L A Liversedge; G M Yuill; I M Wilkinson; J A Hughes
Journal:  J Neurol Neurosurg Psychiatry       Date:  1974-04       Impact factor: 10.154

4.  Corticosteroids in management of severe, generalized myasthenia gravis. Effectiveness and comparison with corticotropin therapy.

Authors:  N G Brunner; T Namba; D Grob
Journal:  Neurology       Date:  1972-06       Impact factor: 9.910

5.  The use of ACTH and corticosteroids in myasthenia gravis.

Authors:  G Genkins; P Kornfeld; K E Osserman; T Namba; D Grob; N G Brunner
Journal:  Ann N Y Acad Sci       Date:  1971-09-15       Impact factor: 5.691

6.  Corticosteroids: a direct effect at the neuromuscular junction.

Authors:  R W Wilson; M D Ward; T R Johns
Journal:  Neurology       Date:  1974-11       Impact factor: 9.910

Review 7.  President's address. Myasthenia gravis.

Authors:  J W Turner
Journal:  Proc R Soc Med       Date:  1974-08

8.  Myasthenia gravis: a serum factor blocking acetylcholine receptors of the human neuromuscular junction.

Authors:  A N Bender; S P Ringel; W K Engel; M P Daniels; Z Vogel
Journal:  Lancet       Date:  1975-03-15       Impact factor: 79.321

9.  Maintenance adrenocorticotropic hormone (ACTH) treatment in myasthenia gravis.

Authors:  C A Cape; R A Utterback
Journal:  Neurology       Date:  1972-11       Impact factor: 9.910
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.